Loading…

Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis

Objective. To systematically study the mechanism of cordyceps cicadae in the treatment of diabetic nephropathy (DN) with the method of network pharmacology and molecular docking analysis, so as to provide theoretical basis for the development of new drugs for the treatment of DN. Methods. TCMSP, Sym...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes research 2021, Vol.2021, p.5477941-10
Main Authors: Qian, Yi, Sun, Xin, Wang, Xin, Yang, Xin, Fan, Mengyao, Zhong, Jiao, Pei, Zejun, Guo, Junping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43
cites cdi_FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43
container_end_page 10
container_issue
container_start_page 5477941
container_title Journal of diabetes research
container_volume 2021
creator Qian, Yi
Sun, Xin
Wang, Xin
Yang, Xin
Fan, Mengyao
Zhong, Jiao
Pei, Zejun
Guo, Junping
description Objective. To systematically study the mechanism of cordyceps cicadae in the treatment of diabetic nephropathy (DN) with the method of network pharmacology and molecular docking analysis, so as to provide theoretical basis for the development of new drugs for the treatment of DN. Methods. TCMSP, Symmap, PubChem, PubMed, and CTD database were used to predict and screen the active components and therapeutic targets for DN. The network of active components and targets was drawn by Cytoscape 3.6.0, the protein-protein interaction (PPI) was analyzed by the STRING database, and the DAVID database was used for the enrichment analysis of intersection targets. Molecular docking studies were finished by Discovery Studio 3.5. Results. A total of 36 active compounds, including myriocin, guanosine, and inosine, and 378 potential targets of cordyceps cicadae were obtained. PPI network analysis showed that AKT1, MAPK8, and TP53 and other targets were related to both cordyceps cicadae and DN. GO and KEGG pathway analysis showed that these targets were mostly involved in R-HSA-450341, 157.14-3-3 cell cycle, and PDGF pathways. Docking studies suggested that myriocin can fit in the binding pocket of two target proteins (AKT1 and MAPK8). Conclusion. Active ingredients of cordyceps cicadae such as myriocin may act on DN through different targets such as AKT1, MAPK8, and TP53 and other targets, which can help to develop innovative drugs for effective treatment of DN.
doi_str_mv 10.1155/2021/5477941
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_541e3fb1566d48e7969619068cb67ac8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_541e3fb1566d48e7969619068cb67ac8</doaj_id><sourcerecordid>2580586067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43</originalsourceid><addsrcrecordid>eNp9kktv1DAURiMEolXpjjWyxAYJhtqJX9kglSmPSi2wKGvr-pGJp0k8tROqSPx4PMwwoizwxtb10fH9rFsUzwl-SwhjZyUuyRmjQtSUPCqOy4rQBResenw4U3ZUnKa0xnnVVS2ZfFocVZSXpMb0uPh57UwLg089Cg1ahmhn4zYJLb0BCw75Ad1EB6MfVujCg3ajN-iL27QxbGBsZ_QekrMoDLk43od4i761EHswoQurGcFg0XXonJk6iOgimNut6HyAbk4-PSueNNAld7rfT4rvHz_cLD8vrr5-ulyeXy0MLxlZ6MYII3LrtRSCSm2wFZg5jJnksjKMm0Y3TldWU1kJzXJS0IZjTRtbgaHVSXG589oAa7WJvoc4qwBe_S6EuFIQc7DOKUaJqxpNGOeWSidqXvP8U1wazQUYmV3vdq7NpHtnjRvGCN0D6cObwbdqFX4oSeuylHUWvNoLYribXBpV75NxXQeDC1NSJZOY5xf5tu-X_6DrMMX8eTsqx8dcZOrNjjIxpBRdc2iGYLWdErWdErWfkoy_-DvAAf4zExl4vQNaP1i49__X_QKIGMSd</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2580586067</pqid></control><display><type>article</type><title>Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis</title><source>Wiley-Blackwell Open Access Collection</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Qian, Yi ; Sun, Xin ; Wang, Xin ; Yang, Xin ; Fan, Mengyao ; Zhong, Jiao ; Pei, Zejun ; Guo, Junping</creator><contributor>Yu, Liping ; Liping Yu</contributor><creatorcontrib>Qian, Yi ; Sun, Xin ; Wang, Xin ; Yang, Xin ; Fan, Mengyao ; Zhong, Jiao ; Pei, Zejun ; Guo, Junping ; Yu, Liping ; Liping Yu</creatorcontrib><description>Objective. To systematically study the mechanism of cordyceps cicadae in the treatment of diabetic nephropathy (DN) with the method of network pharmacology and molecular docking analysis, so as to provide theoretical basis for the development of new drugs for the treatment of DN. Methods. TCMSP, Symmap, PubChem, PubMed, and CTD database were used to predict and screen the active components and therapeutic targets for DN. The network of active components and targets was drawn by Cytoscape 3.6.0, the protein-protein interaction (PPI) was analyzed by the STRING database, and the DAVID database was used for the enrichment analysis of intersection targets. Molecular docking studies were finished by Discovery Studio 3.5. Results. A total of 36 active compounds, including myriocin, guanosine, and inosine, and 378 potential targets of cordyceps cicadae were obtained. PPI network analysis showed that AKT1, MAPK8, and TP53 and other targets were related to both cordyceps cicadae and DN. GO and KEGG pathway analysis showed that these targets were mostly involved in R-HSA-450341, 157.14-3-3 cell cycle, and PDGF pathways. Docking studies suggested that myriocin can fit in the binding pocket of two target proteins (AKT1 and MAPK8). Conclusion. Active ingredients of cordyceps cicadae such as myriocin may act on DN through different targets such as AKT1, MAPK8, and TP53 and other targets, which can help to develop innovative drugs for effective treatment of DN.</description><identifier>ISSN: 2314-6745</identifier><identifier>EISSN: 2314-6753</identifier><identifier>DOI: 10.1155/2021/5477941</identifier><identifier>PMID: 34621904</identifier><language>eng</language><publisher>England: Hindawi</publisher><subject>Acids ; Adenosine ; Binding sites ; Biological Products - therapeutic use ; Chinese medicine ; Cordyceps - chemistry ; Diabetes ; Diabetic Nephropathies - drug therapy ; Diabetic nephropathy ; Glucose ; Humans ; Keywords ; Kidney diseases ; Medicine, Chinese Traditional ; Metabolism ; Molecular Docking Simulation ; Network Pharmacology ; Pharmacology ; Protein Interaction Maps ; Proteins ; Signal transduction ; Software</subject><ispartof>Journal of diabetes research, 2021, Vol.2021, p.5477941-10</ispartof><rights>Copyright © 2021 Yi Qian et al.</rights><rights>Copyright © 2021 Yi Qian et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2021 Yi Qian et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43</citedby><cites>FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43</cites><orcidid>0000-0001-8878-7044 ; 0000-0002-0563-0058</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2580586067/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2580586067?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,25731,27900,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34621904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Yu, Liping</contributor><contributor>Liping Yu</contributor><creatorcontrib>Qian, Yi</creatorcontrib><creatorcontrib>Sun, Xin</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Yang, Xin</creatorcontrib><creatorcontrib>Fan, Mengyao</creatorcontrib><creatorcontrib>Zhong, Jiao</creatorcontrib><creatorcontrib>Pei, Zejun</creatorcontrib><creatorcontrib>Guo, Junping</creatorcontrib><title>Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis</title><title>Journal of diabetes research</title><addtitle>J Diabetes Res</addtitle><description>Objective. To systematically study the mechanism of cordyceps cicadae in the treatment of diabetic nephropathy (DN) with the method of network pharmacology and molecular docking analysis, so as to provide theoretical basis for the development of new drugs for the treatment of DN. Methods. TCMSP, Symmap, PubChem, PubMed, and CTD database were used to predict and screen the active components and therapeutic targets for DN. The network of active components and targets was drawn by Cytoscape 3.6.0, the protein-protein interaction (PPI) was analyzed by the STRING database, and the DAVID database was used for the enrichment analysis of intersection targets. Molecular docking studies were finished by Discovery Studio 3.5. Results. A total of 36 active compounds, including myriocin, guanosine, and inosine, and 378 potential targets of cordyceps cicadae were obtained. PPI network analysis showed that AKT1, MAPK8, and TP53 and other targets were related to both cordyceps cicadae and DN. GO and KEGG pathway analysis showed that these targets were mostly involved in R-HSA-450341, 157.14-3-3 cell cycle, and PDGF pathways. Docking studies suggested that myriocin can fit in the binding pocket of two target proteins (AKT1 and MAPK8). Conclusion. Active ingredients of cordyceps cicadae such as myriocin may act on DN through different targets such as AKT1, MAPK8, and TP53 and other targets, which can help to develop innovative drugs for effective treatment of DN.</description><subject>Acids</subject><subject>Adenosine</subject><subject>Binding sites</subject><subject>Biological Products - therapeutic use</subject><subject>Chinese medicine</subject><subject>Cordyceps - chemistry</subject><subject>Diabetes</subject><subject>Diabetic Nephropathies - drug therapy</subject><subject>Diabetic nephropathy</subject><subject>Glucose</subject><subject>Humans</subject><subject>Keywords</subject><subject>Kidney diseases</subject><subject>Medicine, Chinese Traditional</subject><subject>Metabolism</subject><subject>Molecular Docking Simulation</subject><subject>Network Pharmacology</subject><subject>Pharmacology</subject><subject>Protein Interaction Maps</subject><subject>Proteins</subject><subject>Signal transduction</subject><subject>Software</subject><issn>2314-6745</issn><issn>2314-6753</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kktv1DAURiMEolXpjjWyxAYJhtqJX9kglSmPSi2wKGvr-pGJp0k8tROqSPx4PMwwoizwxtb10fH9rFsUzwl-SwhjZyUuyRmjQtSUPCqOy4rQBResenw4U3ZUnKa0xnnVVS2ZfFocVZSXpMb0uPh57UwLg089Cg1ahmhn4zYJLb0BCw75Ad1EB6MfVujCg3ajN-iL27QxbGBsZ_QekrMoDLk43od4i761EHswoQurGcFg0XXonJk6iOgimNut6HyAbk4-PSueNNAld7rfT4rvHz_cLD8vrr5-ulyeXy0MLxlZ6MYII3LrtRSCSm2wFZg5jJnksjKMm0Y3TldWU1kJzXJS0IZjTRtbgaHVSXG589oAa7WJvoc4qwBe_S6EuFIQc7DOKUaJqxpNGOeWSidqXvP8U1wazQUYmV3vdq7NpHtnjRvGCN0D6cObwbdqFX4oSeuylHUWvNoLYribXBpV75NxXQeDC1NSJZOY5xf5tu-X_6DrMMX8eTsqx8dcZOrNjjIxpBRdc2iGYLWdErWdErWfkoy_-DvAAf4zExl4vQNaP1i49__X_QKIGMSd</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Qian, Yi</creator><creator>Sun, Xin</creator><creator>Wang, Xin</creator><creator>Yang, Xin</creator><creator>Fan, Mengyao</creator><creator>Zhong, Jiao</creator><creator>Pei, Zejun</creator><creator>Guo, Junping</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8878-7044</orcidid><orcidid>https://orcid.org/0000-0002-0563-0058</orcidid></search><sort><creationdate>2021</creationdate><title>Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis</title><author>Qian, Yi ; Sun, Xin ; Wang, Xin ; Yang, Xin ; Fan, Mengyao ; Zhong, Jiao ; Pei, Zejun ; Guo, Junping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acids</topic><topic>Adenosine</topic><topic>Binding sites</topic><topic>Biological Products - therapeutic use</topic><topic>Chinese medicine</topic><topic>Cordyceps - chemistry</topic><topic>Diabetes</topic><topic>Diabetic Nephropathies - drug therapy</topic><topic>Diabetic nephropathy</topic><topic>Glucose</topic><topic>Humans</topic><topic>Keywords</topic><topic>Kidney diseases</topic><topic>Medicine, Chinese Traditional</topic><topic>Metabolism</topic><topic>Molecular Docking Simulation</topic><topic>Network Pharmacology</topic><topic>Pharmacology</topic><topic>Protein Interaction Maps</topic><topic>Proteins</topic><topic>Signal transduction</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qian, Yi</creatorcontrib><creatorcontrib>Sun, Xin</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Yang, Xin</creatorcontrib><creatorcontrib>Fan, Mengyao</creatorcontrib><creatorcontrib>Zhong, Jiao</creatorcontrib><creatorcontrib>Pei, Zejun</creatorcontrib><creatorcontrib>Guo, Junping</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of diabetes research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qian, Yi</au><au>Sun, Xin</au><au>Wang, Xin</au><au>Yang, Xin</au><au>Fan, Mengyao</au><au>Zhong, Jiao</au><au>Pei, Zejun</au><au>Guo, Junping</au><au>Yu, Liping</au><au>Liping Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis</atitle><jtitle>Journal of diabetes research</jtitle><addtitle>J Diabetes Res</addtitle><date>2021</date><risdate>2021</risdate><volume>2021</volume><spage>5477941</spage><epage>10</epage><pages>5477941-10</pages><issn>2314-6745</issn><eissn>2314-6753</eissn><abstract>Objective. To systematically study the mechanism of cordyceps cicadae in the treatment of diabetic nephropathy (DN) with the method of network pharmacology and molecular docking analysis, so as to provide theoretical basis for the development of new drugs for the treatment of DN. Methods. TCMSP, Symmap, PubChem, PubMed, and CTD database were used to predict and screen the active components and therapeutic targets for DN. The network of active components and targets was drawn by Cytoscape 3.6.0, the protein-protein interaction (PPI) was analyzed by the STRING database, and the DAVID database was used for the enrichment analysis of intersection targets. Molecular docking studies were finished by Discovery Studio 3.5. Results. A total of 36 active compounds, including myriocin, guanosine, and inosine, and 378 potential targets of cordyceps cicadae were obtained. PPI network analysis showed that AKT1, MAPK8, and TP53 and other targets were related to both cordyceps cicadae and DN. GO and KEGG pathway analysis showed that these targets were mostly involved in R-HSA-450341, 157.14-3-3 cell cycle, and PDGF pathways. Docking studies suggested that myriocin can fit in the binding pocket of two target proteins (AKT1 and MAPK8). Conclusion. Active ingredients of cordyceps cicadae such as myriocin may act on DN through different targets such as AKT1, MAPK8, and TP53 and other targets, which can help to develop innovative drugs for effective treatment of DN.</abstract><cop>England</cop><pub>Hindawi</pub><pmid>34621904</pmid><doi>10.1155/2021/5477941</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-8878-7044</orcidid><orcidid>https://orcid.org/0000-0002-0563-0058</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6745
ispartof Journal of diabetes research, 2021, Vol.2021, p.5477941-10
issn 2314-6745
2314-6753
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_541e3fb1566d48e7969619068cb67ac8
source Wiley-Blackwell Open Access Collection; Publicly Available Content (ProQuest); PubMed Central
subjects Acids
Adenosine
Binding sites
Biological Products - therapeutic use
Chinese medicine
Cordyceps - chemistry
Diabetes
Diabetic Nephropathies - drug therapy
Diabetic nephropathy
Glucose
Humans
Keywords
Kidney diseases
Medicine, Chinese Traditional
Metabolism
Molecular Docking Simulation
Network Pharmacology
Pharmacology
Protein Interaction Maps
Proteins
Signal transduction
Software
title Mechanism of Cordyceps Cicadae in Treating Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking Analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A55%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mechanism%20of%20Cordyceps%20Cicadae%20in%20Treating%20Diabetic%20Nephropathy%20Based%20on%20Network%20Pharmacology%20and%20Molecular%20Docking%20Analysis&rft.jtitle=Journal%20of%20diabetes%20research&rft.au=Qian,%20Yi&rft.date=2021&rft.volume=2021&rft.spage=5477941&rft.epage=10&rft.pages=5477941-10&rft.issn=2314-6745&rft.eissn=2314-6753&rft_id=info:doi/10.1155/2021/5477941&rft_dat=%3Cproquest_doaj_%3E2580586067%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6251-bfc7c7985987748bc0d705e0058683c56cfbfeb3db4837b5000abc60b4fd3ac43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2580586067&rft_id=info:pmid/34621904&rfr_iscdi=true